Rite Aid EBITDA 2010-2022 | RAD

Rite Aid ebitda from 2010 to 2022. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Rite Aid Annual EBITDA
(Millions of US $)
2022 $597
2021 $404
2020 $468
2019 $442
2018 $840
2017 $695
2016 $772
2015 $1,298
2014 $1,166
2013 $1,132
2012 $703
2011 $740
2010 $755
2009 $2,447
Rite Aid Quarterly EBITDA
(Millions of US $)
2022-05-31 $49
2022-02-28 $299
2021-11-30 $130
2021-08-31 $52
2021-05-31 $115
2021-02-28 $62
2020-11-30 $130
2020-08-31 $131
2020-05-31 $80
2020-02-29 $192
2019-11-30 $136
2019-08-31 $92
2019-05-31 $48
2019-02-28 $-267
2018-11-30 $126
2018-08-31 $472
2018-05-31 $111
2018-02-28 $181
2017-11-30 $116
2017-08-31 $440
2017-05-31 $102
2017-02-28 $75
2016-11-30 $100
2016-08-31 $281
2016-05-31 $240
2016-02-29 $219
2015-11-30 $362
2015-08-31 $324
2015-05-31 $270
2015-02-28 $345
2014-11-30 $335
2014-08-31 $356
2014-05-31 $262
2014-02-28 $271
2013-11-30 $270
2013-08-31 $313
2013-05-31 $313
2013-02-28 $468
2012-11-30 $302
2012-08-31 $194
2012-05-31 $167
2012-02-29 $131
2011-11-30 $196
2011-08-31 $154
2011-05-31 $222
2011-02-28 $197
2010-11-30 $188
2010-08-31 $138
2010-05-31 $216
2010-02-28 $164
2009-11-30 $214
2009-08-31 $176
2009-05-31 $202
2009-02-28 $1,979
Sector Industry Market Cap Revenue
Retail/Wholesale Retail - Drug Stores $0.275B $24.568B
Rite Aid Corporation is on the front lines of delivering health care services and retail products to over one million Americans daily. It provides an array of whole being health products and services for the entire family through retail pharmacies across states. Through Elixir, pharmacy benefits manager, it provides pharmacy benefits and services nationwide. Its key accomplishments include: i) advancing pharmacy strategy, including rebranding retail stores and Elixir, ii) launching a new member portal at Elixir, iii) expanding business, iv) introducing three flagship remodels and v) expanding COVID-19 testing and vaccinations. The company initiates a strategic plan named RxEvolution, which includes significant rebranding, a merchandising overhaul, new marketing and integration and operational initiatives, in both Retail Pharmacy and Pharmacy Services segments.
Stock Name Country Market Cap PE Ratio
CVS Health (CVS) United States $125.204B 11.13
Herbalife (HLF) United States $2.145B 5.33
GNC Holdings (GNC) United States $0.000B 0.00